December 2, 2022 by Chain Drug Review
CVS, CVS completes rollout of time delay safes in 13 states
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. – Amidst a busy holiday shopping season and as part of an ongoing commitment to support law enforcement and help build safer communities, CVS Health announced the installation of time delay safe technology in 800 CVS Pharmacy locations — including those in Target stores — in 13 states across the U.S. The states
November 17, 2022 by Chain Drug Review
CVS
Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health announced a $14.3 million investment with Chief Seattle Club and Raymond James Affordable Housing Investments to build 120 affordable housing units in Seattle, Washington as part of the company’s commitment to advancing health equity by addressing social determinants of health at the local level. “When people have access to high-quality
November 2, 2022 by Chain Drug Review
CVS, Karen Lynch, Opioid, third quarter
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health easily beat analysts’ sales and earnings estimates for the third quarter and again raised its full year guidance. The company reported adjusted earnings per share $2.09 on revenue of $81.16 billion, which climbed 10% from a year earlier. Wall Street had expected adjusted EPS of $1.99 on revenue of $76.75
October 25, 2022 by Chain Drug Review
CVS, CVS Health has released The Rx Report: A New Day in Retail Pharmacy
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has released The Rx Report: A New Day in Retail Pharmacy, highlighting the results of a CVS Health/Morning Consult survey, which identified strong consumer preference and demand for an expanded role of pharmacists. Released during American Pharmacists Month, the report examines the history and evolution of community pharmacy in America, as
October 17, 2022 by Chain Drug Review
CVS, Katie Pouliot
October 17, 2022, Pharmacy
CRANSTON, R.I. — Pharmacy manager Katie Pouliot was recently surprised by a visit from Ken Hopkins, the mayor of Cranston, the city where the CVS Pharmacy she manages is located. Hopkins had heard that Pouliot was named a national Paragon Award recipient and was there to recognize Pouliot for her service to the community.
October 11, 2022 by Chain Drug Review
CVS, menstrual
Leading Headlines, Retail News
WOONSOCKET, R.I. _CVS Health has reduced the price of private label period products by 25%. CVS also said on its website that it is paying the tax on period products on behalf of customers where and when possible, and is working to help eliminate the tax nationwide. “Here, period health matters,” the web post says. “That’s why
October 6, 2022 by Chain Drug Review
CVS, selling generic Tylenol (acetaminophen) without warning of a potential link to autism if taken during pregnancy, Walgreens, Walmart
Leading Headlines, Pharmacy, Retail News
NEW YORK — On Wednesday a panel of federal judges ordered that more than 80 cases accusing CVS Health, Walgreens Boots Alliance and Walmart of selling generic Tylenol (acetaminophen) without warning of a potential link to autism if taken during pregnancy be consolidated. The cases have been consolidated for multi-district litigation to Judge Denise Cote
September 27, 2022 by Chain Drug Review
CVS, CVS Health is actively preparing for Hurricane Ian's landfall in Florida this week
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health is actively preparing for Hurricane Ian’s landfall in Florida this week. The company’s priority is the health and safety of its colleagues, customers, and members, and it is committed to providing its communities access to the products and services they need to plan for the storm. In advance of Hurricane Ian,
September 21, 2022 by Chain Drug Review
Brian Eason, CVS, FARE
Leading Headlines, Retail News
NEW YORK — Food Allergy Research & Education (FARE) announced Wednesday that CVS Pharmacy is the exclusive retail partner of the FARE Teal Pumpkin Project 2022. This program is a yearly effort to make trick-or-treating safer and more inclusive for the one in 13 children in the U.S. living with food allergies and many others
September 21, 2022 by Chain Drug Review
Attorney General Patrick Morrisey, CVS, Walmart
Leading Headlines, Pharmacy
CHARLESTON, W.Va. — Walmart and CVS Pharmacy have settled with the state of West Virginia for a combined total of $147 million in a lawsuit over the companies’ roles in contributing to the oversupply of prescription drugs that fueled the opioid epidemic in the country’s most impacted state, Attorney General Patrick Morrisey announced Tuesday. Walmart and CVS were
September 2, 2022 by Chain Drug Review
CVS, Walgreens
Leading Headlines, Pharmacy, Retail News
NEW YORK— Walgreens and CVS Pharmacy announced Friday that the redesigned COVID-19 booster shots developed by Pfizer/BioNTech and Moderna will now be available nationwide for eligible individuals aged 12 years and up. The updated COVID-19 booster is developed to more effectively protect against the latest viral variants, including Omicron BA.4 and BA.5, the dominant virus
August 5, 2022 by Chain Drug Review
Anthony Bell, CVS, David Haering, Donna Traefald, Jill Colpitts, Kaitlyn Pouliot, senior leaders. The 2022 Retail Paragon Award winners were recognized and celebrated during CVS Pharmacy’s annual Retail Leadership Experience in Orlando on August 3
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I.— Jill Colpitts, a nurse practitioner at the MinuteClinic on East Cleveland Road in Granger, IN, was one of the winners of the 2022 Paragon Award from CVS Health. The Paragon Award is one of the highest honors a CVS colleague can receive and is reserved for those with exemplary commitment to the company’s
August 5, 2022 by Chain Drug Review
Amwell, CVS
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — Telehealth company Amwell is working with CVS Health to roll out the comapny’s new virtual primary care service. At the end of May, CVS announced plans to launch a virtual care service that gives consumers access to primary care, on-demand care, chronic condition management and mental health services. Eligible Aetna and CVS Caremark members will
August 3, 2022 by Chain Drug Review
CVS, Karen Lynch, second quarter
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health easily beat analysts’ projections for second quarter sales and earnings, and raised its full-year profit outlook. The company posted adjusted earnings per share of $2.40, topping Wall Street’s average forecast of $2.17. Net income was $2.96 billion, or $2.23 per share, up from $2.79 billion, or $2.10 per share, a